- Home
- CISS vs NTBL Comparison
CISS vs NTBL Comparison
Compare CISS & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- NTBL
- Stock Information
- Founded
- CISS 2022
- NTBL 2000
- Country
- CISS Greece
- NTBL United States
- Employees
- CISS N/A
- NTBL N/A
- Industry
- CISS Marine Transportation
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- CISS Consumer Discretionary
- NTBL Health Care
- Exchange
- CISS Nasdaq
- NTBL Nasdaq
- Market Cap
- CISS 11.9M
- NTBL 4.6M
- IPO Year
- CISS N/A
- NTBL N/A
- Fundamental
- Price
- CISS $1.16
- NTBL $0.34
- Analyst Decision
- CISS
- NTBL Buy
- Analyst Count
- CISS 0
- NTBL 2
- Target Price
- CISS N/A
- NTBL $5.00
- AVG Volume (30 Days)
- CISS 146.9K
- NTBL 8.0M
- Earning Date
- CISS 11-01-2024
- NTBL 11-12-2024
- Dividend Yield
- CISS N/A
- NTBL N/A
- EPS Growth
- CISS N/A
- NTBL N/A
- EPS
- CISS N/A
- NTBL N/A
- Revenue
- CISS $47,503,090.00
- NTBL $313,000.00
- Revenue This Year
- CISS N/A
- NTBL N/A
- Revenue Next Year
- CISS N/A
- NTBL N/A
- P/E Ratio
- CISS N/A
- NTBL N/A
- Revenue Growth
- CISS 264.29
- NTBL 3812.50
- 52 Week Low
- CISS $1.08
- NTBL $0.22
- 52 Week High
- CISS $68.50
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- CISS 49.27
- NTBL 43.04
- Support Level
- CISS $1.08
- NTBL $0.28
- Resistance Level
- CISS $1.25
- NTBL $0.67
- Average True Range (ATR)
- CISS 0.05
- NTBL 0.06
- MACD
- CISS 0.01
- NTBL -0.00
- Stochastic Oscillator
- CISS 47.06
- NTBL 27.53
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.